Navigation Links
Rutgers establishes stem cell repository for the study of mental health disorders
Date:10/21/2011

Rutgers University Cell and DNA Repository (RUCDR) has established a stem cell repository for the National Institute of Mental Health that will better enable researchers to study a variety of mental health disorders, including autism, attention deficit disorder, major depression, and schizophrenia, that affect millions of Americans.

"The biology of mental health disorders has been especially difficult to study because brain tissue from affected individuals is seldom available," said principal investigator Jay A. Tischfield, Duncan and Nancy Macmillan Professor and director of the Human Genetics Institute. "With the award of this new grant, we will provide researchers with new biological tools that will greatly enhance our understanding of the biological basis of mental disorders."

The NIMH Repository Supporting Stem Cell Research will be part of the existing NIMH Center for Collaborative Genetic Studies on Mental Disorders which has been based at Rutgers since 1998 when NIMH awarded Rutgers $96 million to establish cell lines, DNA and RNA for the NIMH Genetics Initiative by collecting samples from families with a wide range of mental health disorders. The center's goal which is being expanded with a $1.2 million stem cell supplement is to increase the repertoire of resources to researchers around the world.

Tischfield says researchers at the new Rutgers-based NIMH Stem Cell Center will use skin or other cells from people with mental health disorders, such as schizophrenia, to create stem cells within two to three months that can then become brain cells such as neurons. Up until now, research on the causes and treatment of mental health disorders has been hampered by the fact that brain tissue from someone with the mental disorder was seldom available until they died, a time when brain cells are quickly degrading.

The new method to create stem cells called induced pluripotent stem cells (iPS) produces human stem cells that are similar to embryonic stem cells, but which do not require embryonic material for their establishment. iPS cells originate from adult body cells that are reprogrammed in the laboratory by inserting foreign genes into the cell, enabling it to become any type of cell in the body. The new stem cells could provide scientists with the necessary clues they need to determine the causes of mental disorder and develop effective drugs to combat them.

"It is amazing that we can take a tiny piece of skin from a person with a particular disease, comprised of cells that were thought of as recently as several years ago as being in a terminal state of differentiation, and turn back the clock to induce those cells to become stem cells that have the potential to become a neuron, or a heart cell, or any of a number of cell types," said Michael Sheldon, assistant research professor in the Department of Genetics and the project's co-director.

The collaboration between Rutgers and the National Institute of Mental Health will provide researchers throughout the world studying causes of mental health and other diseases with iPS cells derived from people with anxiety disorders, attention deficit hyperactivity disorder, autism, spectrum disorders, bipolar disorder, borderline personality disorder, depression, eating disorders, obsessive compulsive disorder, panic disorder, post-traumatic stress disorder and schizophrenia, to better understand how these diseases originate and progress.

The RUCDR is the largest repository in the world and provides DNA, RNA and cell lines to hundreds of research laboratories across the globe studying mental health disorders and drug and alcohol abuse as well as the causes of digestive, liver, and kidney disease, and diabetes.


'/>"/>

Contact: Robin Lally
rlally@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

Related biology news :

1. Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments
2. Rutgers, UMDNJ research provides unprecedented insight into fighting viral infections
3. Rutgers, UMDNJ receive $23 million to develop antidotes for chemical weapons attacks
4. Rutgers laboratory helped to create new HIV drug
5. Rutgers offers hope in new treatment for spinal cord injuries
6. $1,820,000 from NSF awarded to Rutgers-Newark to acquire fMRI dedicated to research
7. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
8. NIH awards Rutgers $47.5 million to advance groundbreaking research on protein structures
9. Rutgers-Camden professor engineers E. coli to produce biodiesel
10. Rutgers researchers assess severity of prostate cancers using magnetic resonance imaging
11. Rutgers researchers discover secrets of nutritious corn breed that withstands rigors of handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the ... corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, and ... reason for its increasing popularity is due to its new team building format, a way ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
Breaking Biology Technology: